Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/BEIGENE-LTD-26123632/actualite/BeiGene-Ltd-recoit-un-avis-positif-du-CHMP-pour-le-tislelizumab-en-tant-que-traitement-du-cancer-46053050/?utm_source=whatsapp&utm_medium=social&utm_campaign=share